SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending due to anticipation surrounding its earnings report and its potential impact on the AI sector, with community discussions focusing on new partnerships and whether the stock is overvalued. Key talking points include potential investments and the possibility of a post-earnings sell-off versus a rally. The company's role in the AI supply chain and its monopolistic pricing are also being debated.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGL is trending following news of Berkshire Hathaway taking a significant stake in the company, signaling confidence in its AI and data center initiatives. The community is discussing the implications of this investment, with many viewing it as a bullish signal, while some debate whether the stock is currently overvalued. Broader discussions include Google's AI leadership, competition in the search engine space, and the potential for future growth.

Alphabet Inc - Ordinary Shares - Class C

GOOG is trending as investors discuss the implications of Alphabet's Gemini 3 AI model launch and its potential impact on the competitive landscape with OpenAI. Community members are also reacting to news of a significant investment by Berkshire Hathaway, sparking debates about valuation and future growth prospects for the tech giant. Some traders are looking at technical indicators and potential resistance levels, while others focus on broader sector trends and the increasing demand for AI infrastructure.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending as investors react to news of a large bond offering and a Rothschild downgrade, leading to discussions about AI spending and near-term growth prospects. The community is debating whether the recent pullback represents a buying opportunity or signals deeper issues, with some expressing frustration over the stock's underperformance compared to its tech peers. Despite strong earnings, AMZN is struggling to maintain gains, prompting concerns about market manipulation and the company's long-term strategy.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target's stock is trending as investors digest recent earnings and guidance, with discussions focused on the impact of consumer spending trends and a planned AI partnership. Community perspectives are split, with some seeing a buying opportunity due to cost-cutting measures and a focus on customer experience, while others express concerns about competition and broader economic headwinds. The announcement of a new CEO and a major investment in store upgrades and technology are also key talking points.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal ($PYPL) is trending downwards, frustrating many investors as it declines despite positive market movement and seemingly strong fundamentals. Community sentiment is largely bearish, with concerns over the company's growth prospects and management decisions. Some investors speculate about potential buybacks or acquisitions as possible catalysts for a turnaround.

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Kazia Therapeutics Limited - ADR

Kazia Therapeutics

KZIA is trending as traders discuss recent clinical data showcasing a complete response in a metastatic triple-negative breast cancer patient treated with its paxalisib combo regimen. While some community members express skepticism and anticipate shorting opportunities on perceived fake green candles, others highlight the potential for a short squeeze and long-term gains. The overall conversation reflects the high-risk, high-reward nature of biotech stocks, with traders closely monitoring volume and price action.

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.

Tempest Therapeutics Inc

TPST is trending as investors digest the implications of the company's strategic acquisition of new dual-CAR T programs and concurrent leadership changes. The community is actively debating whether this signals a shift in direction and its potential impact on a possible buyout, with some expressing concerns about dilution. Chatter revolves around how the deal with Factor impacts existing pipelines and speculation about potential partnerships with larger pharmaceutical firms.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio (NUVB) is trending as the community discusses its market potential, citing Citizens' increased stock price target and strong Ibtrozi sales. Bullish sentiment is fueled by clarity on key points from the recent quarter and call, including Ibtrozi's strong uptake and Safusidenib's promising pipeline. Some traders attribute recent price action to overall market conditions and profit-taking, while others eagerly anticipate news of a European partnership.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending amid positive sentiment following Jefferies naming it a top pick with a raised price target, citing growth in AI-related business with major clients. The community is actively discussing the potential for significant revenue growth and earnings expansion, particularly related to custom AI chips, with some comparing it favorably to other AI plays. However, some traders are expressing caution due to overall market conditions and potential overvaluation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BETRF Great piece that accurately captures BETRF&#39;s current position. So if you want to refresh your understanding of BETRF or learn about BETRF for the first time, this is essential reading. https://beyondspx.com/quote/BETRF/analysis/betterlife-pharma-unlocking-value-through-novel-neuroplastogens-and-interferon-therapies-betrf

BetterLife Pharma Inc. is a clinical-stage biotechnology company focused on developing innovative treatments for mental disorders, including non-hallucinogenic neuroplastogens, and interferon-based th...

BeyondSPX

BetterLife Pharma: Unlocking Value Through Novel Neuroplastogens and Interferon Therapies (BETRF) - BETRF Stock Analysis

StockTwits Web

BetterLife Pharma Inc

 Great piece that accurately captures BETRF's current position. So if you want to refresh your understanding of BETRF or learn about BETRF for the first time, this is essential reading. 